Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-02-11T05:15:07.411Z Has data issue: false hasContentIssue false
  • English
  • Français

Observations on the Effect of Largactil in Psychiatric Illness

Published online by Cambridge University Press:  08 February 2018

A. A. Baker
A. A. Baker*
Affiliation:
Fairdene and Netherne Hospitals
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Largactil is one of the phenothiazine group of compounds. It is, therefore, related to promethazine (phenergan) and diethazine (diparcol). It is also known as R.P. 4560 and chlorpromazine. It has been used on the Continent in psychiatric cases since 1951, because of the relaxation and calm it produces. It has been on trial at Netherne Hospital since 1953 and 80 patients have received this treatment.

Type
Original Articles
Information
Journal of Mental Science , Volume 101 , Issue 422 , January 1955 , pp. 175 - 182
Copyright
Copyright © Royal College of Psychiatrists, 1955 

References

1. Sigwald, J., and Bouttier, D., Annales de Medicine, 1953, 54, 150.Google Scholar
2. British Medical Journal, 1953, ii, 1149.Google Scholar
3. Deschamps, A., and Cadoret, M., Presse Medicale, 1953, 61, 878.Google Scholar
4. Genetic Psychology Monographs, 1953, 47, 237–301.Google Scholar
5. Dixon, W. J., and Mood, A. M., J. American Statistical Association, 1946, 41, 557.Google Scholar
6. Lindsley, D. B., Bowden, J. W., and Magoun, H. W., E.E.G. Clin. Neurophysiol., 1949, 1, 475.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.